Key Takeaways -
As stocks surge in reaction to news about COVID-19-related products and solutions, the SEC is actively working to protect investors from misleading statements, fraud, and even investment scams relating to the...more
7/13/2020
/ Biotechnology ,
Coronavirus/COVID-19 ,
Disclosure Requirements ,
Enforcement Actions ,
Investor Protection ,
Life Sciences ,
Material Misstatements ,
Popular ,
Risk Assessment ,
Risk Mitigation ,
Scams ,
Securities and Exchange Commission (SEC) ,
Vaccinations